Skip to main content
. Author manuscript; available in PMC: 2023 Nov 23.
Published in final edited form as: Ann Allergy Asthma Immunol. 2022 Jan 12;128(4):414–422.e2. doi: 10.1016/j.anai.2022.01.007

Figure 2:

Figure 2:

Immunofluorescence staining of eosinophil-derived EDN and MBP at dpi 4. 2A. Representative staining. 2B: Summary of expression of EDN. **p<0.01. 2C: Summary of expression of MBP. 2D: Nasal wash EDN concentrations as determined by EIA. **p<0.01 atopic compared to controls. #p<0.05 atopic subjects day 4 compared to day 0.